TRAVERE THERAPEUTICS, INC. (TVTX) Shareholders’ equity 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) shareholders’ equity at each fiscal year-end, per SEC filings.
$114.8MFY2025 · since FY2016: $307.8M → $114.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $114.8M | +94.4% |
| FY2024 | $59.1M | -70.6% |
| FY2023 | $200.8M | +368.6% |
| FY2022 | $42.9M | -85.8% |
| FY2021 | $302.1M | +43.0% |
| FY2020 | $211.2M | -4.5% |
| FY2019 | $221.2M | -30.5% |
| FY2018 | $318.3M | +8.6% |
| FY2017 | $293.1M | -4.8% |
| FY2016 | $307.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice